| Poonam Khadka, MD | |
|
900 Broadway, Bangor, ME 04401-1900 | |
| (207) 907-1187 | |
| (207) 907-1189 |
| Full Name | Poonam Khadka |
|---|---|
| Gender | Female |
| Speciality | Endocrinology |
| Experience | 19 Years |
| Location | 900 Broadway, Bangor, Maine |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750652822 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | MD20656 (Maine) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Joseph Hospital | Bangor, ME | Hospital |
| Millinocket Regional Hospital | Millinocket, ME | Hospital |
| Mount Desert Island Hospital | Bar harbor, ME | Hospital |
| Houlton Regional Hospital | Houlton, ME | Hospital |
| Mayo Regional Hospital | Dover foxcroft, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Joseph Hospital | 6406766336 | 155 |
News Archive
CardiAQ Valve Technologies (CardiAQ), which performed the first ever Trans-Femoral, Transcatheter Mitral Valve Implantation procedure in June of 2012 with its self-conforming, self-anchoring implant technology, announced today that it has achieved another milestone in cardiovascular medicine by successfully implanting its Second Generation Transcatheter Mitral Valve in an 88-year-old female suffering from severe mitral regurgitation (MR 4+) using the company's newly added Trans-Apical Delivery System.
Archimedes Inc., a healthcare modeling company, announced today that it has entered into a Research Collaboration Agreement with the U.S. Food and Drug Administration (FDA) to develop a computer model of clinical trials evaluating weight loss medications. The model will be used to obtain a better understanding of the benefits of weight loss against the long-term risks of cardiovascular outcomes in patients treated with weight loss drugs.
Dendreon Corporation today announced that the U.S. Food and Drug Administration approved its Los Angeles cancer immunotherapy manufacturing facility, allowing the company to continue to increase the availability of PROVENGE across the U.S. to help meet the needs of patients with asymptomatic or minimally symptomatic metastatic castrate resistant prostate cancer.
ABC News interviewed President Barack Obama, who said: "The Senate certainly shouldn't try to jam anything through until Scott Brown is seated. People in Massachusetts spoke. He's got to be part of that process. ... I think point number two is that it is very important to look at the substance of this package and for the American people to understand that a lot of the fear mongering around this bill isn't true. I would advise that we try to move quickly to coalesce around those elements of the package that people agree on" (Stephanopoulos, 1/20).
Removing electronic media from the bedroom and encouraging a calming bedtime routine are among recommendations Penn State researchers outline in a recent manuscript on digital media and sleep in childhood and adolescence.
› Verified 6 days ago
| Entity Name | St Joseph Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154321545 PECOS PAC ID: 6406766336 Enrollment ID: O20040604000895 |
News Archive
CardiAQ Valve Technologies (CardiAQ), which performed the first ever Trans-Femoral, Transcatheter Mitral Valve Implantation procedure in June of 2012 with its self-conforming, self-anchoring implant technology, announced today that it has achieved another milestone in cardiovascular medicine by successfully implanting its Second Generation Transcatheter Mitral Valve in an 88-year-old female suffering from severe mitral regurgitation (MR 4+) using the company's newly added Trans-Apical Delivery System.
Archimedes Inc., a healthcare modeling company, announced today that it has entered into a Research Collaboration Agreement with the U.S. Food and Drug Administration (FDA) to develop a computer model of clinical trials evaluating weight loss medications. The model will be used to obtain a better understanding of the benefits of weight loss against the long-term risks of cardiovascular outcomes in patients treated with weight loss drugs.
Dendreon Corporation today announced that the U.S. Food and Drug Administration approved its Los Angeles cancer immunotherapy manufacturing facility, allowing the company to continue to increase the availability of PROVENGE across the U.S. to help meet the needs of patients with asymptomatic or minimally symptomatic metastatic castrate resistant prostate cancer.
ABC News interviewed President Barack Obama, who said: "The Senate certainly shouldn't try to jam anything through until Scott Brown is seated. People in Massachusetts spoke. He's got to be part of that process. ... I think point number two is that it is very important to look at the substance of this package and for the American people to understand that a lot of the fear mongering around this bill isn't true. I would advise that we try to move quickly to coalesce around those elements of the package that people agree on" (Stephanopoulos, 1/20).
Removing electronic media from the bedroom and encouraging a calming bedtime routine are among recommendations Penn State researchers outline in a recent manuscript on digital media and sleep in childhood and adolescence.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Poonam Khadka, MD C/o St Marys Health System - Provider Enrollment, Po Box 7291, Lewiston, ME 04243-7291 Ph: (207) 777-8560 | Poonam Khadka, MD 900 Broadway, Bangor, ME 04401-1900 Ph: (207) 907-1187 |
News Archive
CardiAQ Valve Technologies (CardiAQ), which performed the first ever Trans-Femoral, Transcatheter Mitral Valve Implantation procedure in June of 2012 with its self-conforming, self-anchoring implant technology, announced today that it has achieved another milestone in cardiovascular medicine by successfully implanting its Second Generation Transcatheter Mitral Valve in an 88-year-old female suffering from severe mitral regurgitation (MR 4+) using the company's newly added Trans-Apical Delivery System.
Archimedes Inc., a healthcare modeling company, announced today that it has entered into a Research Collaboration Agreement with the U.S. Food and Drug Administration (FDA) to develop a computer model of clinical trials evaluating weight loss medications. The model will be used to obtain a better understanding of the benefits of weight loss against the long-term risks of cardiovascular outcomes in patients treated with weight loss drugs.
Dendreon Corporation today announced that the U.S. Food and Drug Administration approved its Los Angeles cancer immunotherapy manufacturing facility, allowing the company to continue to increase the availability of PROVENGE across the U.S. to help meet the needs of patients with asymptomatic or minimally symptomatic metastatic castrate resistant prostate cancer.
ABC News interviewed President Barack Obama, who said: "The Senate certainly shouldn't try to jam anything through until Scott Brown is seated. People in Massachusetts spoke. He's got to be part of that process. ... I think point number two is that it is very important to look at the substance of this package and for the American people to understand that a lot of the fear mongering around this bill isn't true. I would advise that we try to move quickly to coalesce around those elements of the package that people agree on" (Stephanopoulos, 1/20).
Removing electronic media from the bedroom and encouraging a calming bedtime routine are among recommendations Penn State researchers outline in a recent manuscript on digital media and sleep in childhood and adolescence.
› Verified 6 days ago
Eddy Karnabi, MD PHD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1 Northeast Dr, Bangor, ME 04401 Phone: 207-275-3800 | |
Dr. Theodore William James, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 417 State St Ste 121, Bangor, ME 04401 Phone: 207-973-4266 | |
Fnu Kaleemullah, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 489 State St, Bangor, ME 04401 Phone: 207-973-7314 | |
Sverrir I Gunnarsson, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1 Northeast Dr, Bangor, ME 04401 Phone: 207-275-3800 | |
Liga Yusvirazi, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 360 Broadway, Bangor, ME 04401 Phone: 207-907-3283 | |
Ilsa Annetta Shulman, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 900 Broadway, Bangor, ME 04401 Phone: 207-907-3300 Fax: 207-907-1923 | |
Dr. Michael Paul Sighinolfi, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 360 Broadway Ste 100, Bangor, ME 04401 Phone: 207-907-3550 Fax: 207-907-3562 |